相似文献
1
The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist.
Br J Clin Pharmacol. 1986 Apr;21(4):393-400. doi: 10.1111/j.1365-2125.1986.tb05213.x.
2
Changes in cardiovascular responsiveness to dopexamine and beta 1- and beta 2-adrenoceptor function after the chronic treatment of beta-adrenoceptor antagonists and agonists in anaesthetized dogs.
J Auton Pharmacol. 1996 Oct;16(5):269-79. doi: 10.1111/j.1474-8673.1996.tb00361.x.
3
[Dopexamine: a new dopaminergic agonist].
Ann Fr Anesth Reanim. 1993;12(3):308-20. doi: 10.1016/s0750-7658(05)80658-6.
4
Acute haemodynamic and metabolic effects of dopexamine, a new dopaminergic receptor agonist, in patients with chronic heart failure.
Br Heart J. 1985 Sep;54(3):313-20. doi: 10.1136/hrt.54.3.313.
5
Beneficial haemodynamic effects of intravenous dopexamine in patients with low-output heart failure.
J Cardiovasc Pharmacol. 1987 Sep;10(3):280-6. doi: 10.1097/00005344-198709000-00005.
6
Arrhythmogenic potential of dopexamine hydrochloride during halothane anaesthesia in dogs.
Can J Anaesth. 1994 Jun;41(6):542-6. doi: 10.1007/BF03011552.
7
Inotropic mechanisms of dopexamine hydrochloride in horses.
Am J Vet Res. 1992 Aug;53(8):1343-6.
8
Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
Int J Cardiol. 1991 Feb;30(2):203-8. doi: 10.1016/0167-5273(91)90096-8.
9
Role of the beta 2 adrenoceptor in mediating positive inotropic activity in the failing heart and its relation to the hemodynamic actions of dopexamine hydrochloride.
Am J Cardiol. 1988 Aug 11;62(5):46C-52C. doi: 10.1016/s0002-9149(88)80067-5.
10
Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
Am J Cardiol. 1988 Aug 11;62(5):63C-67C. doi: 10.1016/s0002-9149(88)80070-5.
引用本文的文献
1
Circulatory and diuretic effects of dopexamine infusion in low-birth-weight infants with respiratory failure.
Intensive Care Med. 1996 Jan;22(1):65-70. doi: 10.1007/BF01728334.
2
Studies on the pharmacological interventions to prevent oxygen free radical (OFR)-mediated toxicity; effects of dopexamine, a DA1 receptor and beta 2 adrenoceptor agonist.
Naunyn Schmiedebergs Arch Pharmacol. 1994 Sep;350(3):277-83. doi: 10.1007/BF00175033.
3
Comparison of the effects of dopamine, dobutamine, and dopexamine upon renal blood flow: a study in normal healthy volunteers.
Br J Clin Pharmacol. 1988 May;25(5):555-60. doi: 10.1111/j.1365-2125.1988.tb03345.x.
4
Haemodynamic response to dopexamine hydrochloride in postinfarction heart failure: lack of tolerance after continuous infusion.
Br Heart J. 1988 Dec;60(6):489-96. doi: 10.1136/hrt.60.6.489.
5
Failure of dopexamine to maintain haemodynamic improvement in patients with chronic heart failure.
Br Heart J. 1988 Jul;60(1):45-9. doi: 10.1136/hrt.60.1.45.
6
Inhibition of Uptake1 by dopexamine hydrochloride in vitro.
Br J Pharmacol. 1987 Oct;92(2):265-70. doi: 10.1111/j.1476-5381.1987.tb11320.x.
7
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
Basic Res Cardiol. 1989;84 Suppl 1:177-86. doi: 10.1007/BF02650357.
8
The effects of dopexamine, a new dopamine analogue, on platelet function in stress.
Br J Clin Pharmacol. 1990 Jul;30(1):87-95. doi: 10.1111/j.1365-2125.1990.tb03747.x.
9
Dopexamine hydrochloride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in acute cardiac insufficiency.
Drugs. 1990 Feb;39(2):308-30. doi: 10.2165/00003495-199039020-00009.
本文引用的文献
1
Salbutamol in treatment of heart failure.
Br Heart J. 1980 Feb;43(2):206-10. doi: 10.1136/hrt.43.2.206.
2
Analysis of left ventricular pressure during isovolumic relaxation in coronary artery disease.
Circulation. 1982 Apr;65(4):690-7. doi: 10.1161/01.cir.65.4.690.
3
Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.
Circulation. 1983 Mar;67(3):620-6. doi: 10.1161/01.cir.67.3.620.
4
Drugs five years later. Dobutamine.
Ann Intern Med. 1983 Oct;99(4):490-6. doi: 10.7326/0003-4819-99-4-490.
5
Differential distribution of beta-1 and beta-2 adrenergic receptors in cat and guinea-pig heart.
J Pharmacol Exp Ther. 1980 Mar;212(3):503-8.
6
A model of asynchronous left ventricular relaxation predicting the bi-exponential pressure decay.
Cardiovasc Res. 1983 Aug;17(8):482-8. doi: 10.1093/cvr/17.8.482.
7
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
Eur Heart J. 1982 Dec;3 Suppl D:129-34.
8
Beta-adrenoceptors of the human myocardium: determination of beta 1 and beta 2 subtypes by radioligand binding.
Br J Pharmacol. 1983 Dec;80(4):711-7. doi: 10.1111/j.1476-5381.1983.tb10062.x.
9
Cardiovascular and renal actions of dopamine: potential clinical applications.
Pharmacol Rev. 1972 Mar;24(1):1-29.
10
Intropic effect of tachycardia and poststimulation potentiation in the conscious dog.
Am J Physiol. 1974 Sep;227(3):569-75. doi: 10.1152/ajplegacy.1974.227.3.569.
Zotero 插件